Location History:
- Kasukabe, JP (1986 - 1988)
- Tokyo, JP (2004)
Company Filing History:
Years Active: 1986-2004
Title: Fumitake Shimada: Innovator in Physiologically Active Substances
Introduction
Fumitake Shimada is a notable inventor based in Kasukabe, Japan. He has made significant contributions to the field of pharmacology, particularly in the development of physiologically active substances derived from mushrooms. With a total of 3 patents, his work has garnered attention for its potential health benefits.
Latest Patents
Shimada's latest patents include a groundbreaking invention related to a physiologically active substance known as EEM-S, which originates from mushrooms. This substance is produced through a process that involves extracting compounds from selected mushrooms using hot water or lower alcohol. The extract is then treated using the molecular sieve method to eliminate both low-molecular-weight and high-molecular-weight fractions. EEM-S has been shown to exert various physiological effects, including anticancer, immunopotentiating, antioxidative, hypotensive, and hypoglycemic effects. Another significant patent involves 13-propylberberine salts, which demonstrate strong inhibitory effects against secretion, good stability, and high water solubility. These effects are observed promptly after oral administration.
Career Highlights
Throughout his career, Fumitake Shimada has worked with several companies, including Ss Pharmaceutical Co., Ltd. and Life Science Laboratories Co., Ltd. His innovative research has contributed to advancements in the pharmaceutical industry, particularly in the development of new therapeutic agents.
Collaborations
Shimada has collaborated with notable coworkers such as Tetsuro Ikekawa and Jong-Chol Cyong. These partnerships have further enhanced his research and development efforts in the field of pharmacology.
Conclusion
Fumitake Shimada's contributions to the field of physiologically active substances highlight his role as an influential inventor. His innovative patents and collaborations have the potential to impact health and medicine significantly.